Vor Biopharma Inc
VORBuild a strategy around VOR
Vor Biopharma Inc AI Insights
Informational only. Not investment advice.Snapshot
- Zero revenue with -367M TTM operating loss; 160M cash remaining covers ~13 months at current -144M annual burn rate[Cash and Equivalents]
- Negative equity of -2.2B driven by -790M investment loss (TTM) - balance sheet technically insolvent[Common Stockholders Equity]
- R&D spend of 328M TTM is 8.7x industry median (38M) - heavy clinical investment with no revenue offset[Research and Development]
Watch Triggers
- Cash and Equivalents: Falls below 100M — Would signal <9 months runway, forcing emergency financing at distressed terms
- Issuance of Capital Stock: Exceeds 50M quarterly — Heavy dilution signal; current 20M TTM pace insufficient for survival
- Total Revenue: Any positive revenue recognition — Would indicate partnership deal or milestone payment - thesis-changing event
Bull Case
Pre-revenue biotech with 328M R&D investment; clinical success could transform valuation from 81M market cap
Minimal debt (3M) and low capex (<1M TTM) means cash funds R&D directly, not servicing obligations
Bear Case
Negative equity (-2.2B) with liabilities of 2.4B creates existential balance sheet risk; P/B ratio meaningless at -0.04
13-month cash runway at current burn requires imminent dilution; 6.7M shares could expand significantly
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage VOR's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Cash runway exhaustion likely within 12-18 months without dilutive financing or partnership
- 160M cash vs 144M annual burn
- Zero revenue generation
- 20M equity issuance TTM insufficient
Valuation Context
Caveats
VOR Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$778.11M | — | ||
$611.18M | — | ||
0.00 | — | ||
$0 | — | ||
$0.00 | — | ||
0% | — | ||
0% | — | ||
$0 | — | ||
0% | — | ||
Beta 5Y (Monthly) | unknown | — |
VOR Dividend History
VOR Stock Splits
VOR SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
05/13/26 | 03/31/26 | 10-Q | |
03/30/26 | 12/31/25 | 10-K | |
11/13/25 | 09/30/25 | 10-Q | |
08/12/25 | 06/30/25 | 10-Q | |
05/14/25 | 03/31/25 | 10-Q | |
03/20/25 | 12/31/24 | 10-K | |
03/30/26 | 12/31/24 | 10-K | |
11/07/24 | 09/30/24 | 10-Q | |
08/08/24 | 06/30/24 | 10-Q | |
05/09/24 | 03/31/24 | 10-Q | |
03/20/25 | 12/31/23 | 10-K | |
03/20/24 | 12/31/23 | 10-K | |
11/07/23 | 09/30/23 | 10-Q | |
08/10/23 | 06/30/23 | 10-Q | |
05/11/23 | 03/31/23 | 10-Q | |
03/23/23 | 12/31/22 | 10-K | |
11/10/22 | 09/30/22 | 10-Q | |
08/11/22 | 06/30/22 | 10-Q | |
05/12/22 | 03/31/22 | 10-Q | |
03/14/22 | 12/31/21 | 10-K | |
11/10/21 | 09/30/21 | 10-Q | |
08/09/21 | 06/30/21 | 10-Q | |
05/06/21 | 03/31/21 | 10-Q | |
03/25/21 | 12/31/20 | 10-K | |
02/08/21 | 09/30/20 | 424B4 | |
08/09/21 | 06/30/20 | 10-Q | |
05/06/21 | 03/31/20 | 10-Q | |
02/08/21 | 12/31/19 | 424B4 |